Related Experiment Video
Updated: Feb 14, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Molecular Landscape of Resected Thymomas: Insights from Mutational Profiling
Luca Frasca1, Antonio Sarubbi1,2, Lorenzo Nibid3,4
1Department of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
Abstract:
Background/Objectives: Thymomas are the most common tumors of the anterior mediastinum. While early-stage disease often has a favorable prognosis, therapeutic options in advanced stages remain limited. Moreover, the molecular profile of thymomas is still poorly characterized. In the present study, we explored the presence of targetable mutations and programmed death-ligand 1 (PD-L1) expression in a cohort of surgically resected thymomas. Furthermore, we investigated the correlation between PD-L1 expression, histological subtype, and risk of recurrence in patients who underwent curative-intent thymectomy. Methods: Mutational profiling was performed using a DNA-based NGS Cancer Panel of 16 genes. PD-L1 expression was evaluated via Tumor Proportion Score (TPS), and thymomas with TPS ≥ 50% were identified as high expressors. The associations with histological subtype and disease-free survival (DFS) were analyzed using logistic regression, Cox proportional hazards models, and Kaplan-Meier survival curves. Results: In our study, 2/37 (5.4%) of tested neoplasms (type AB and B2 thymoma) reported as a PIK3CA mutation; no other targetable mutations were observed. Moreover, high PD-L1 expression (≥50%) was reported in (15/37) 40.5% of patients and was significantly associated with aggressive histological subtypes (B2 and B3) (p < 0.001). Logistic regression analysis showed that high PD-L1 expression was a significant predictor of aggressive histology (McFadden's R2 = 0.268, p < 0.001), with an odds ratio of 15.5 (95% CI: 2.9-83.4; p = 0.001). During follow-up, 5/37 (13.5%) of patients experienced disease recurrence; however, no significant difference in DFS was found between high and low PD-L1 expression groups. Conclusions: Our data confirm the presence of PIK3CA mutations in thymomas and encourage the exploration the potential role of molecular target therapy in this setting. Moreover, we underlined that high PD-L1 expression level is associated with more aggressive thymoma subtypes and may have a role as a prognostic biomarker. These findings support the need for further studies on the potential role of molecular and predictive pathology in thymic epithelial tumors.
Insights
This study found PIK3CA mutations in thymomas and that high programmed death-ligand 1 (PD-L1) expression is linked to aggressive subtypes, suggesting potential biomarkers for thymic tumors.
Area of Science:
- Oncology
- Molecular Pathology
Background:
- Thymomas are common anterior mediastinum tumors with limited advanced-stage treatment options.
- The molecular profile of thymomas requires further characterization.
- Targetable mutations and PD-L1 expression in thymomas are not well understood.
Purpose of the Study:
- To investigate targetable mutations and PD-L1 expression in thymomas.
- To explore the correlation between PD-L1 expression, histological subtype, and recurrence risk.
- To assess the potential of PD-L1 as a prognostic biomarker in thymic epithelial tumors.
Main Methods:
- Next-generation sequencing (NGS) Cancer Panel for 16 genes.
- PD-L1 expression assessment using Tumor Proportion Score (TPS) (≥50% defined as high expressors).
- Statistical analysis including logistic regression, Cox models, and Kaplan-Meier curves.
Main Results:
- PIK3CA mutations were identified in 5.4% of thymomas; no other targetable mutations were found.
- High PD-L1 expression (≥50%) was observed in 40.5% of patients and significantly associated with aggressive histological subtypes (B2/B3) (p < 0.001).
- High PD-L1 expression strongly predicted aggressive histology (OR=15.5, p=0.001), but no significant difference in disease-free survival was observed between PD-L1 expression groups.
Conclusions:
- PIK3CA mutations are present in thymomas, warranting investigation into molecular targeted therapies.
- High PD-L1 expression is associated with aggressive thymoma subtypes and may serve as a prognostic biomarker.
- Further research into molecular and predictive pathology is crucial for thymic epithelial tumors.
More Related Videos
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Molecular Models
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms

